000 01381 a2200397 4500
005 20250518025022.0
264 0 _c20191203
008 201912s 0 0 eng d
022 _a1532-3080
024 7 _a10.1016/j.breast.2019.01.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aColas, Chrystelle
245 0 0 _a"Decoding hereditary breast cancer" benefits and questions from multigene panel testing.
_h[electronic resource]
260 _bBreast (Edinburgh, Scotland)
_cJun 2019
300 _a29-35 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aEarly Detection of Cancer
_xmethods
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aGenes, BRCA2
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenetic Testing
_xmethods
650 0 4 _aGenetic Variation
650 0 4 _aHumans
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aReproducibility of Results
650 0 4 _aSequence Analysis
_xmethods
700 1 _aGolmard, Lisa
700 1 _ade Pauw, Antoine
700 1 _aCaputo, Sandrine M
700 1 _aStoppa-Lyonnet, Dominique
773 0 _tBreast (Edinburgh, Scotland)
_gvol. 45
_gp. 29-35
856 4 0 _uhttps://doi.org/10.1016/j.breast.2019.01.002
_zAvailable from publisher's website
999 _c29429838
_d29429838